Saphris (SA-fris), a new atypical antipsychotic for schizophrenia and bipolar disorder

Reps will promote Saphris (SA-fris), a new atypical antipsychotic for schizophrenia and bipolar disorder.

They will point out that Saphris (asenapine) is well tolerated.

Saphris seems to cause less weight gain and other metabolic problems than risperidone (Risperdal, etc) or olanzapine (Zyprexa, etc).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote